A Wide-Ranging Analysis on Ethosomes

International Journal of Pharmacy and Biomedical Engineering

© 2015 by SSRG - IJPBE Journal

Volume 2 Issue 2

Year of Publication : 2015

Authors : K.Matilda and G.Charlotte

10.14445/23942576/IJPBE-V2I2P101

How to Cite?

K.Matilda and G.Charlotte, "A Wide-Ranging Analysis on Ethosomes," SSRG International Journal of Pharmacy and Biomedical Engineering, vol. 2,  no. 2, pp. 1-4, 2015. Crossref, https://doi.org/10.14445/23942576/IJPBE-V2I2P101

Abstract:

Ethosomes are noninvasive release carriers that facilitate drugs to attain the deep skin layers and the universal movement. Though ethosomal systems are theoretically complicated, they are effortless in their training, safe for use an arrangement that can highly enlarge their relevance. Ethosomes are soft, compliant vesicles tailored for improved liberation of vigorous agents. Because of their exclusive organization, ethosomes can encapsulate and deliver during the skin highly lipophilic molecules such as cannabinoids, testosterone, and minoxidil, as well as cationic drugs such as propranolol, trihexaphenidyl, Cyclosporine, insulin, salbutamol etc.
      Improved release of bioactive molecules during the skin and cellular membranes by means of an ethosomal delivery service opens numerous challenges and opportunities for the research and future improvement of novel improved therapies. Ethosomes are gaining a reputation in designing drug delivery systems for topical and transdermal use for their ability to reach deep skin layers and universal circulation. Although ethosomes are theoretically complicated, they are simple in training and safe for use. Although with their high efficiency, the ethosomes show possible for the development of their applications. The aim of the review to make an inclusive description of properties and training of ethosomes followed by the classification and the list of drugs encapsulated in ethosomes.

Keywords:

Ethosomes, malleable vesicles, ethosomal carrier, Transdermal

References:

[1] Godin B, Tauitou Elka. (2005) Current Drug Delivery. 2: 269‐275.
[2] Akiladev D, Basak S, (2010) International Journal of Current pharmaceutical research. 2(4): 1-4.
[3] Dave A, (2010) International Journal of Drug Delivery. 2: 81-92
[4] Hadgraft J, Guy R. “Transdermal Drug Delivery, Developmental Issues and Research Initiatives”. New York: Marcel Dekker, 1989.
[5] Chourasia MK, (2011), Nanosized ethosomes are bearing ketoprofen for improved transdermal delivery, Results in Pharma Sciences (1); 60–67.
[6] Michaels AS, Chandrasekaran SK, Shaw JW. (1975) “Drug permeation through human skin: theory and in vitro experimental measurement”. AlChE 21: 985-96.
[7] Mustafa MA., Elsayed, (2006) International Journal of Pharmaceutics (322); 60–66.
[8] Pilgram GS. (1999) J Invest Derm 113: 403–409.
[9] Verma P, (2011) Nanomedicine: Nanotechnology, Biology, and Medicine, 1-8.
[10] Rahul G.S. Maheshwari, Rakesh K. Tekade, Piyoosh A. Sharma, Gajanan Darwhekar, Abhishek Tyagi, Rakesh P. Patel, Dinesh K., (2012), Jain Saudi Pharmaceutical Journal, Volume 20, Issue 2, Pages 161-170.
[11] Schreier H, Bouwstra JA. (1994) J Control Rel. 30:1 15.
[12] Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. (2000) J Control Release 65: 403-18.
[13] Vijayakumar MR, (2010) International Journal of Pharmacy and Pharmaceutical Sciences 2(4).82-86.
[14] Williams ML, Elias PM. The extracellular matrix of stratum corneum: the role of lipids in normal and pathological function. Crit rev Therapy drug carrier Systems (1987) 3: 95–122.
[15] Zhen Zhang, (2011) Nanomedicine: Nanotechnology, Biology, and Medicine, 1-7.
[16] Sathalia et al., Int J Pharm Pharm Sci, Vol 2, Issue 4, 8286
[17] Jha AK, (2011) Der Pharmacia Sinica, , 2(4):192-202
[18] Shingade G, (2012) International Journal of Universal Pharmacy and Life Sciences 2(3)
[19] Naimi TS, LeDell KH, Como-Sabetti K (2003) JAMA, 290:2976–84.
[20] Kaplun-Frisckhoff Y, Touitou E, (1997) J. Pharm. Sci., 86:1394-1399
[21] Kirjavainen M, Urtti A, Valjakka KR, Kiesvaara Jm, (1997) Eur. J. Pharm. Sci. (1999)7(4): 279- 286.
[22] Subjeet J, Ashok KT, Bharti S, Narendra KJ. (2007) AAPS Pharm SciTech 8(4): E1 – E9.
[23] Dayan N, Touitou E, (2000) Biomaterials 21: 1879 – 1885.
[24] Jun Shi, Yiming Wang and Guoan Luo, (2012), AAPS PharmSciTech, Volume 13, Number 2, Pages 485-492
[25] Fiddan AP, Yeo JM, Strubbings R, Dean D. (1983) Vesicular Approach for Drug Delivery into or Across the Skin Br. Med. J. 286, 701,1699.